All In Biotech

Drug Trial Radar · NCT06625957

Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition

A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 Versus NTCB-C in Patients Who Require Parenteral Nutrition

Last checked: Nov 19, 2026Latest source record: Jan 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Dec 4, 2024

Primary completion

Jul 18, 2025

Study completion Jul 18, 2025

Sponsor

Lead sponsor
Yuhan CorporationIndustry
Sponsor type
Industry
First posted
Oct 3, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 versus NTCB-C in patients who require parenteral nutrition

Conditions

  • Parenteral Nutrition

Interventions

  • NTCB02-1Drug

    3 Days infusion

  • NTCB-CDrug

    3 Days infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Occurance rate of adverse drug reactionTime frame: Day 1 to day 4

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • National Cancer Center

    Gyeonggi-do, Goyang-si, South Korea · Recruiting

  • Chonnam National University Hwasun Hospital

    Jeollanam-do, Hwasun-gun, South Korea · Recruiting

  • Jeonbuk National University Hospital

    Jeollabuk-do, Jeonju-si, South Korea · Recruiting

  • Severance Hospital

    Seoul, Seodaemun-gu, South Korea · Recruiting

  • Seoul National University Bundang

    Gyeonggi-do, Seongnam-si, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.